Publication | Closed Access

Tamoxifen reduces the risk of contralateral breast cancer in premenopausal women: Results from a controlled randomised trial

Breast OncologyMedicineGynecologyCancer PreventionBreast CancerContralateral Breast CancerPremenopausal WomenOncologyRadiation OncologyEndocrine-related CancerWomen's Health